References
- Thomas J M, Misiewicz G. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer. Clin Gastroenterol 1984; 13: 501–542
- Bardhan K D. Omeprazole in the management of refractory duodenal ulcer. Scand J Gastroenterol 1989; 24(suppl 166)63–73
- Schwarz K, Beitz Z. Ueber penetriende magen und jejunalgeschwure. Klin Chir 1910; 67: 96–128
- Soil A H. Peptic ulcer diseases. Perspectives on pathophysiology and therapy. J Clin Gastroenterol 1989; 11(suppl 1)
- Rademaker J W, Hunt R H. Acid and barriers. Current research and future developments for peptic ulcer therapy. Scand J Gastroenterol 1990; 25(suppl 175)
- Konturek S J, Kwiecien N, Swierczek J, Oleksy J, Sito E, Robert A. Comparison of methylated prostaglandin E2 analogs given orally in the inhibition of gastric responses to pentagastrin and peptone meal in men. Gastroenterology 1976; 760: 683–687
- Soil A H. Specific inhibition by prostaglandin E2 and 12 of histamine stimulated [14C] aminopyrine accumulation and cyclic adenosine monophosphate generation by isolated canine parietal cells. J Clin Invest 1980; 650: 1222–1229
- Beinborn M, Netz S, Staar U, Sewing K-F R. Localization and characterization of prostaglandin E2 receptors in the porcine fundic mucosa. Gastroenterology 1986; 90: 1343
- Walt R P. Prostaglandins and peptic ulcer therapy. Scand J Gastroenterol 1990; 25(suppl 174)29–36
- Lanza F L, Aspinal R L, Swabb E A, Davis R E, Rack M F, Rubin A. A double blind placebo controlled effects of misoprostal and cimetidine on tolmetin induced gastric mucosal injury. Gastroenterology 1987; 92: 1491
- Agrawal N M, Tulane V, Roth S. Misoprostol co-administration heals aspirin-induced gastric lesions in rheumatoid arthritis patients. Gastroenterology 1987; 92: 1290
- Konturek S J. Mechanisms of gastroprotection. Scand J Gastroenterol 1990; 25(suppl 174)15–28
- Losert W, Loge O, Raduchel B, Skuballa W. Nocloprost. Drugs Fut 1986; 11: 660–662
- Konturek S J, Brzozowski T, Drozdowicz D, et al. Nocloprost, a unique PGE2 analog with local gastroprotective and ulcer healing activity. Eur J Pharmacol 1991; 195: 247–357
- Konturek S J, Konturek J W, Kwiecien N, et al. Gastric protection by nocloprost against aspirin damage in humans. Scand J Gastroenterol 1991; 26: 231–236
- George J D. New clinical method for measuring the rate of gastric emptying: the double sample test meal. Gut 1968; 8: 237–242
- Konturek S J, Kwiecien N, Obtulowicz W, Kopp B, Oleksy J, Rovati L. Cholecystokinin in the inhibition of gastric secretion and gastric emptying in humans. Digestion 1990; 45: 1–8
- McLauchlan G, Rawlings J M, Lucas M L, McCloy R F, Crean G P, McColl K EL. Electrodes for 24 hour pH monitoring—a comparative study. Gut 1787; 28: 935–939
- Krawiec J, Pdes H S, Schwartz B, Lamprecht S A. Regional difference in ambient intraluminal gastric acidity after cimetidine monitored by intragastric pH-metry. Am J Gastroenterol 1983; 78: 272–275
- Emde C, Garner A, Blum A L. Technical aspects of intraluminal pH-metry in man: current status and recommendations. Gut 1987; 28: 1177–1188
- Gabryelewicz A, Kulesza E, Konturek S J. Comparison of loxiglumide a cholecystokinin receptor antagonist and atropine on hormonal and meal stimulated pancreatic secretion in man. Scand J Gastroenterol 1990; 25: 731–738
- Tabata K, Okade S. Gastric secretory conditions and plasma gastrin levels in rats after prolonged treatment with cometidine. Dig Dis Sci 1984; 29: 40–45
- Lind T, Cederberg C, Olausson M, Olbe L. 24-hour intragastric acidity and plasma gastrin after omeprazole and after proximal gastric vagotomy in duodenal ulcer patients. Gastroenterology 1990; 99: 1593–1599
- Vane J R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971; 231: 232–235
- Perr N J. Cimetidine and gastrointestinal bleeding in critically ill patients. Gut 1986; 27: 122–123